David Einhorn acquired 1.27 Million Coya Therapeutics shares worth $11 Million. That's 0.52% of their equity portfolio (24th largest holding). The investor owns 15.79% of the outstanding Coya Therapeutics stock. The stake costed the investor $6.6 Million, netting the investor a gain of 66% so far.